TYME $ 1.45 news https://www.tymeinc.com/investors/news-releases/press-release-details/2019/TYME-and-The-Joseph-Ahmed-Foundation-Announce-Initiation-of-the-HopES-Phase-II-Trial-Evaluating-the-Potential-Benefits-of-SM-88-for-Patients-with-High-Risk-Sarcomas/default.aspx